EP3510044 - Bibliographic data
ANALOGUES DE L'AMYLINE
| Last update | 03/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Zealand Pharma A/S Sydmarken 11
2860 Søborg
Danemark
|
|---|---|
| (72) Inventors |
Jesper Mosolff MATHIESEN 3520 Farum
Danemark
Lise GIEHM 2000 Frederiksberg
Danemark
Henrik Kofoed MUNCH 2000 Frederiksberg
Danemark
Jesper Skodborg VILLADSEN 2740 Skovlunde
Danemark
Dieter Wolfgang HAMPRECHT 55216 Ingelheim am Rhein
Allemagne
Alexander HEIM-RIETHER 55216 Ingelheim am Rhein
Allemagne
Giacomo FOSSATI 55216 Ingelheim am Rhein
Allemagne
|
| (74) Agent |
Mail recipient Mewburn Ellis LLP Aurora Building
Counterslip
Bristol BS1 6BX
Royaume-Uni
|
| (21) Request number | EP17761907.9 |
|---|---|
| (22) Request date | 11/09/2017 |
| (11) Publication number | EP3510044 |
|---|---|
| Publication date | 24/11/2021 |
| (54) Title of the invention | ANALOGUES DE L'AMYLINE |
|---|---|
| (51) International classification | C07K 14/575, A61K 38/22, A61P 5/48 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 16188024 |
|---|---|
| Initial application | None |
| Divisional application | EP21209103.7 /EP4074729 None |
| Expected annuity |
Annuity: 6 -
Amount: 130 € -
Due date 30/09/2022
Surtax: 6 - Amount: 26 € - Due date 03/04/2023 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 24/11/2021 Entrée en période de grâce du brevet d'invention - Legal date 01/10/2022 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2022 |